A detailed history of Simplify Asset Management Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 343,609 shares of ADMA stock, worth $6.14 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
343,609
Previous 385,188 10.79%
Holding current value
$6.14 Million
Previous $6.61 Million 3.21%
% of portfolio
0.28%
Previous 0.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

SELL
$15.44 - $20.61 $641,979 - $856,943
-41,579 Reduced 10.79%
343,609 $6.82 Million
Q4 2024

Feb 11, 2025

BUY
$15.62 - $22.62 $6.02 Million - $8.71 Million
385,188 New
385,188 $6.61 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.51B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.